Table 1.
Characteristics of the study group including the age of patients, level of cervical intraepithelial neoplasia, results of LBC, and HPV status with the genotype of the virus.
| Characteristic | Value |
|---|---|
| Mean age | 32.00 |
| Histological outcome | |
| CIN 1 | 38 (44.7%) |
| CIN 2 | 24 (28.2%) |
| CIN 3 | 19 (22.4%) |
| No pathology | 4 (4.7%) |
| E4 protein level, Me (Q1; Q3) | 108.02 (35.60; 1712.73) |
| HPV L1 level, Me (Q1; Q3) | 5008.66 (154.65; 13,688.40) |
| LBC result, n (%) | |
| NILM | 3 (3.5%) |
| ASC-US | 15 (17.6%) |
| ASC-H | 16 (18.8%) |
| LSIL | 37 (43.5%) |
| HSIL | 13 (15.3%) |
| None | 1 (1.2%) |
| HPV status | |
| PV (+) | 75 (88.2%) |
| PV (−) | 10 (11.8%) |
| HPV genotype, n (%) | |
| 16 | 40 (53.3%) |
| 18 | 5 (6.7%) |
| 31 | 12 (16.0%) |
| 45 | 4 (5.3%) |
| 6 | 9 (12.0%) |
| Other genotypes | 5 (6.7%) |
CIN—cervical intraepithelial neoplasia; HPV—human papillomavirus; LBC—liquid-based cytology; NILM—negative for intraepithelial lesion or malignancy; ASC-US—atypical squamous cells of undetermined significance; ASC-H—atypical squamous cells—cannot exclude HSIL; LSIL—low-grade squamous intraepithelial lesion; and HSIL—high-grade squamous intraepithelial lesion.